Location History:
- Madison, WI (US) (2009 - 2010)
- San Diego, CA (US) (2022)
Company Filing History:
Years Active: 2009-2022
Title: Innovations by Bryan R Becklund in Multiple Sclerosis Treatment
Introduction
Bryan R Becklund is an accomplished inventor based in Madison, WI (US), known for his significant contributions to the field of medical treatments for multiple sclerosis. With a total of three patents to his name, Becklund has focused on innovative methods that aim to alleviate the symptoms of this challenging condition.
Latest Patents
One of Becklund's latest patents is a method of treating multiple sclerosis. This invention involves a method and computer program product designed to suppress the symptoms of multiple sclerosis (MS) by irradiating a subject exhibiting these symptoms with a predetermined dose of UV-containing light from a light source. The unique aspect of this method is that the detected suppression of clinical symptoms is disassociated from vitamin D production within the subject. Another notable patent is the use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis. This method involves administering an effective amount of calcitonin, calcitonin-like peptides, or calcitonin mimetics to a patient, potentially in combination with 1,25-dihydroxyvitamin D analogs.
Career Highlights
Bryan R Becklund is associated with the Wisconsin Alumni Research Foundation, where he continues to develop and refine his innovative approaches to treating multiple sclerosis. His work is characterized by a commitment to improving patient outcomes through scientific research and technological advancements.
Collaborations
Becklund has collaborated with notable colleagues in his field, including Hector Floyd Deluca and Terrence F Meehan. These partnerships have likely contributed to the development and success of his innovative treatments.
Conclusion
Bryan R Becklund's work in the field of multiple sclerosis treatment showcases his dedication to innovation and improving the lives of those affected by this condition. His patents reflect a deep understanding of the complexities of MS and a commitment to finding effective solutions.